A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women

Abstract

The human teratogenic potential of chlordiazepoxide is debated. To study the effects on the fetal development of very large doses of chlordiazepoxide that were used for a suicide attempt during pregnancy, self-poisoned pregnant women were identified from patients in a toxicological inpatient clinic in Budapest, Hungary. Comparisons were made between congenital abnormalities, intrauterine fetal development, and cognitive–behavioral status of the exposed children born to mothers who attempted suicide with chlordiazepoxide alone or in combination with other drugs during pregnancy and their sib controls. Of 1044 women with self-poisoning during pregnancy between 1960 and 1993, 88 (8.4%) used chlordiazepoxide with or without other drugs for suicide attempt; 35 of these women delivered live-born infants. Doses of chlordiazepoxide taken ranged between 20 and 300 mg, with a mean of 117 ± 86 mg. Of 35 exposed children, six (17.1 %) were affected with congenital abnormalities compared with three (13.6%) of their 22 sibs (OR with 95% CI: 1.3 (0.3–4.4). Of 18 pregnant women who attempted suicide between the 4th and 12th postconceptional week, the period most sensitive to congenital malformation, four delivered live-born children affected with a congenital abnormality (atrial septal defect type II, complex defect of respiratory system, mild pyelectasis because of the stenosis of ureteropelvic junction, congenital inguinal hernia). Two other children had fetal alcohol syndrome and unrecognized multiple congenital abnormality including talipes equinovarus, deformation type, and four minor anomalies. The pregnancy age–specific mean birth weight indicated intrauterine fetal growth retardation, which was confirmed by a dose–response relationship and by the higher rate of low birth–weight newborns. Cognitive status and behavioral scale of exposed children did not indicate neurotoxic effects. Very large doses of chlordiazepoxide used for suicide attempts during pregnancy did not induce a higher rate of congenital abnormalities but were associated with dose-dependent intrauterine growth retardation.

Keywords

chlordiazepoxide congenital abnormalities intrauterine growth retardation cognitive and behavioral development suicide attempt during pregnancy

Get full access to this article

View all access options for this article.

References

Bracken MB Holford TR (1981) Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 58: 336–344.

Briggs GG Freeman RK Yaffe S (2005) Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, seventh ed. Baltimore: Lippincott Williams and Wilkins.

Buttar HS (1980) Effects of chlordiazepoxide on the pre- and postnatal development of rats. Toxicology 17: 311–321.

Crombie DL Pinsent RJ Fleming DM Rumean-Rouquette C Goujard J Huel G (1975) Fetal effects of tranquilizers in pregnancy. N Engl J Med 293: 198–199.

Czeizel AE (1986) Self-poisoning as a model for the study of mutagenicity and teratogenicity of chemicals on human beings. In: C Ramel B Lambert J Magnusson (eds), Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis. New York: Alan R. Liss, pp. 237–244.

Czeizel AE Gidai J Petik D Timmermann G Puhó EH (2008) Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Ind Health 24: 11–28.

Czeizel AE Lendvay A (1989) Attempted suicide and pregnancy. Am J Obstet Gynecol 161: 497 (only).

Czeizel AE Mosonyi A (1997) Monitoring of early human fetal development in women exposed to large doses of chemicals. Environ Mol Mutagen 30: 240–244.

Czeizel AE Rockenbauer M Sorensen HT Olsen J (2004a) A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. Neurotoxicol Teratol 26: 593–598.

10.

Czeizel AE Petik D Puho E (2004b) Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Cent Eur J Public Health 12: 179–183.

11.

Czeizel AE Rockenbauer M Siffel, Cs, Varga, E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 63: 176–185.

12.

Czeizel AE Szentesi I Szekeres I Glauber A Bucski P Molnár G (1984) Pregnancy outcome and health conditions of offspring of self-poisoned pregnant women. Acta Paediatr Hung 25: 209–236.

13.

Czeizel AE Szentesi I Szekeres I Molnár G Glauber A Bucski P (1988) A study of adverse effects on the progeny after intoxication during pregnancy. Arch Toxicol 62: 1–7.

14.

Czeizel AE Tomcsik J Tímár L (1997) Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol 90: 195–201.

15.

FDA : Food and Drug Administration (1980) Fetal risk summary. Fed Regist 44: 37434–37467.

16.

Friedman JM Polifka JE (1996) The Effects of Drugs on the Fetus and Nursing Infant. Baltimore: Johns Hopkins Univ Press.

17.

Guram MS Gill TS Geber WF (1982) Comparative teratogenicity of chlordiazepoxide, amitriptyline, and a combination of the two compounds in the fetal hamster. Neurotoxicology 3: 83–90.

18.

Hartz SC Heinonen OP Shapiro S Siskind V Slone D (1975) Antenatal exposure to meprobomate and chlordiazepoxide in relation to malformations, mental development and childhood mortality. N Engl J Med 292: 726–728.

19.

Heinonen OP Slone D Shapiro S (1977) Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group.

20.

Jorgensen NP Thurmann-Nielsen E Walstad RA (1988) Pharmacokinetics and distribution of diazepam and oxazepam in early pregnancy. Acta Obstet Gynecol Scand 67: 493–497.

21.

Kanto JH (1982) Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 23: 354–380.

22.

Kanto J Erkkola R Sellman R (1973) Accumulation of diazepam and N-demethyldiazepam in the fetal blood during labour. Ann Clin Res 5: 375–379.

23.

Kullander S Kallen B (1976) A prospective study of drugs and pregnancy. I. Psychopharmaca. Acta Obstet Gynecol Scand 55: 25–33.

24.

Lendvay A Czeizel AE (1992) A behavioral teratologic study on offspring of self-poisoned pregnant women. Acta Paediatr Hung 32: 347–369.

25.

Milkovich L Van den Berg BJ (1974) Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med 291: 1268–1271.

26.

Rosa F (1993) cit. Briggs, GG, Friedman, RK, Yaffe, SJ (2005) Drugs in Pregnancy and Lactation, seventh ed. Philadelphia: Lippincott Williams and Wilkins.

27.

Rothman KJ Fyler DC Goldblatt A Keridberg MB (1979) Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 109: 433–439.

28.

Saito H Kobayashu S Takeno S Sakai T (1984) Fetal toxicity of benzodizepines in rats. Res Commun Clin Pathol Pharmacol 46: 437–377.

29.

Shepard TH Lemire RJ (2004) Catalog of Teratogenic Agents, eleventh ed. Baltimore: Johns Hopkins Univ. Press.

30.

Stirrat GM Edington DJ Berry DJ (1974) Transplacental passage of chlordiazepoxide. Br Med J 2: 719 (only).

31.

Szegal B . (1980) Diagnostic of psychomotor development. Hung Psychol 2: 148–188.

32.

Usdin E Skolnick P Tallman JF (1982) Pharmacology of Benzodiazepines. London: Macmillan.

33.

Vitéz M Korányi G Gönczy E Rudas T Czeizel A (1984) A semiquantitative score system for epidemiological studies of fetal alcohol syndrome. Am J Epidemiol 119: 301–308.

34.

Wyss S Maier C (1960) Erfahrungen mit dem neuen Psyhosedativum “Librium” (Ro 5-0690) bei einem internistischen Krankengut. Schweiz Med Wochenschr 45: 1293–1296.